← Leaderboards
Aimee Marie Crago
Sloan-Kettering Inst Can Research
$2,751,471
Attributed
$2,751,471
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $558.1K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,751,471 · 1
By mechanism
R37$2,751,471 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- James A Fagin$27,970,638
- Cristina R Antonescu$10,810,455
- Xiang Zhang$12,735,442
- Arvin Dar$9,617,218
- Gregoire Altan-Bonnet$9,103,421
Others in their field
Other Emerging Leaders on “Dna Sequence Alteration”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
- Thomas J Bell · National Disease Research Interchange$8,698,122
- J. Silvio Gutkind · University Of California, San Diego$8,095,498
- Bing Yao · Emory University$6,534,389
Research focus
Dna Sequence AlterationCtnnb1 GeneAdriamycin PfsDisease ProgressionAggressive FibromatosisAbdomenAdverse Event RiskBay 54-9085Benefits And RisksAffectBindingBiological MarkersBiologyAdultBiopsy SpecimenCcnd1 GeneCell ProliferationCellsCessation Of LifeCharacteristicsBeta CateninContractureCounselingDruggable Target
Grant awards (5)
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis$530,202
R37 · FY2024 · CA · contact PI
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis$546,945
R37 · FY2023 · CA · contact PI
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis$558,108
R37 · FY2022 · CA · contact PI
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis$558,108
R37 · FY2021 · CA · contact PI
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis$558,108
R37 · FY2020 · CA · contact PI